_id

695fb8c9c2e91020a7bd42a3

Ticker

0ILL.LSE

Name

Laboratorios Farmaceuticos Rovi S.A

Exchange

LSE

Address

Calle JosE Isbert, 2, Madrid, Spain, 28223

Country

UK

Sector

Industry

Currency

EUR

Website

https://www.rovi.es

Description

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Hibor, a low-molecular-weight heparin to prevent and treat venous thromboembolic disease; Enoxaparin biosimilar Becat, a low-molecular-weight heparin; Neparvis to treat symptomatic chronic heart failure with reduced ejection in adult patients; Absorcol, Vytorin, and Orvatez to diet in patients with hypercholesterolemia; Hirobriz Breezhaler and Ulunar Breezhaler that are long-acting bronchodilators for the maintenance treatment of chronic obstructive pulmonary diseases; Volutsa for treatment of moderate to severe storage systems symptoms and voiding symptoms associated with benign prostatic hyperplasia in men who are not responding adequately to monotherapy treatment; and Medikinet and Medicebrán to treat attention deficit hyperactivity disorder in children and teenagers. The company also markets various hospital products for imaging diagnosis, such as Iomeron and Iopamiro for computed tomography and intervention; Multihance and Prohance for magnetic resonance imaging; Sonovue for ultrasounds; and EmpowerCTA+, EmpowerMR, and CT Exprès that are contrast injection systems and compatible disposable material. It provides non-prescription pharmaceutical products; and contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, hard capsules, and sachets. The company serves wholesalers, doctors, nursing staff, pharmacists, and patients. It has a collaboration with Moderna, Inc. for manufacturing mRNA COVID-19 vaccine candidate. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.

Last Close

67.7

Volume

2930

Current Price

67.9154

Change

0.9844

Last Updated

2026-01-08T14:01:45.266Z

Ipo Date

-

Market Cap

3980582144

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

210473000

Cost Of Revenue

70129000

Gross Profit

140344000

Operating Expenses

72362000

Operating Income

67982000

Interest Expense

757000

Pretax Income

75696000

Net Income

58029000

Eps

1.1344979377901225

Dividends Per Share

47830000

Shares Outstanding

49309000

Income Tax Expense

17685000

EBITDA

83847000

Operating Margin

32.299629881267435

Total Other Income Expense Net

7714000

Cash

49250000

Short Term Investments

-

Receivables

191507000

Inventories

314785000

Total Current Assets

559187000

Property Plant Equipment

304626000

Total Assets

922069000

Payables

102225000

Short Term Debt

26305000

Long Term Debt

-

Total Liabilities

289268000

Equity

621737000

Bs_currency_symbol

-

Depreciation

7469000

Change In Working Capital

-24000

Cash From Operations

72850000

Capital Expenditures

16991000

Cash From Investing

-17622000

Cash From Financing

-52092000

Net Change In Cash

3136000

Cf_currency_symbol

-

PE

0.2014

PB

5.587312024970688

ROE

9.33336764580522

ROA

6.293346810271248

FCF

55859000

Fcf Percent

0.265397461907228

Piotroski FScore

4

Health Score

78

Deep Value Investing Score

7.5

Defensive Investing Score

7

Dividend Investing Score

3.5

Economic Moat Investing Score

9.5

Garp Investing Score

8.5

Growth Investing Score

7

Momentum Investing Score

4.5

Net Net Investing Score

4

Quality Investing Score

8.5

Value Investing Score

7

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

210473000

Quarters > 0 > income Statement > cost Of Revenue

70129000

Quarters > 0 > income Statement > gross Profit

140344000

Quarters > 0 > income Statement > operating Expenses

72362000

Quarters > 0 > income Statement > operating Income

67982000

Quarters > 0 > income Statement > interest Expense

757000

Quarters > 0 > income Statement > pretax Income

75696000

Quarters > 0 > income Statement > net Income

58029000

Quarters > 0 > income Statement > eps

1.1344979377901225

Quarters > 0 > income Statement > dividends Per Share

47830000

Quarters > 0 > income Statement > shares Outstanding

51149498

Quarters > 0 > income Statement > income Tax Expense

17685000

Quarters > 0 > income Statement > EBITDA

83847000

Quarters > 0 > income Statement > operating Margin

32.299629881267435

Quarters > 0 > income Statement > total Other Income Expense Net

7714000

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

49250000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

191507000

Quarters > 0 > balance Sheet > inventories

314785000

Quarters > 0 > balance Sheet > total Current Assets

559187000

Quarters > 0 > balance Sheet > property Plant Equipment

304626000

Quarters > 0 > balance Sheet > total Assets

922069000

Quarters > 0 > balance Sheet > payables

102225000

Quarters > 0 > balance Sheet > short Term Debt

26305000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

289268000

Quarters > 0 > balance Sheet > equity

621737000

Quarters > 0 > balance Sheet > currency_symbol

-

Quarters > 0 > cash Flow > net Income

58029000

Quarters > 0 > cash Flow > depreciation

7469000

Quarters > 0 > cash Flow > change In Working Capital

-24000

Quarters > 0 > cash Flow > cash From Operations

72850000

Quarters > 0 > cash Flow > capital Expenditures

16991000

Quarters > 0 > cash Flow > cash From Investing

-17622000

Quarters > 0 > cash Flow > cash From Financing

-52092000

Quarters > 0 > cash Flow > net Change In Cash

3136000

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

1.1344979377901225

Quarters > 0 > ratios > PB

5.587312024970688

Quarters > 0 > ratios > ROE

9.33336764580522

Quarters > 0 > ratios > ROA

6.293346810271248

Quarters > 0 > ratios > FCF

55859000

Quarters > 0 > ratios > Piotroski FScore

4

Quarters > 0 > ratios > fcf Percent

0.265397461907228

Quarters > 0 > health Score

78

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

159698000

Quarters > 1 > income Statement > cost Of Revenue

61880000

Quarters > 1 > income Statement > gross Profit

97818000

Quarters > 1 > income Statement > operating Expenses

70450000

Quarters > 1 > income Statement > operating Income

27368000

Quarters > 1 > income Statement > interest Expense

699000

Quarters > 1 > income Statement > pretax Income

26777000

Quarters > 1 > income Statement > net Income

21635000

Quarters > 1 > income Statement > eps

0.4229758032033863

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

51149498

Quarters > 1 > income Statement > income Tax Expense

5153000

Quarters > 1 > income Statement > EBITDA

34933000

Quarters > 1 > income Statement > operating Margin

17.137346741975477

Quarters > 1 > income Statement > total Other Income Expense Net

-591000

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

46114000

Quarters > 1 > balance Sheet > short Term Investments

1507000

Quarters > 1 > balance Sheet > receivables

136366000

Quarters > 1 > balance Sheet > inventories

327669000

Quarters > 1 > balance Sheet > total Current Assets

516304999

Quarters > 1 > balance Sheet > property Plant Equipment

294247000

Quarters > 1 > balance Sheet > total Assets

869605000

Quarters > 1 > balance Sheet > payables

56327000

Quarters > 1 > balance Sheet > short Term Debt

27941000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

294890000

Quarters > 1 > balance Sheet > equity

563634000

Quarters > 1 > balance Sheet > currency_symbol

-

Quarters > 1 > cash Flow > net Income

21635000

Quarters > 1 > cash Flow > depreciation

7467000

Quarters > 1 > cash Flow > change In Working Capital

-15354000

Quarters > 1 > cash Flow > cash From Operations

8704000

Quarters > 1 > cash Flow > capital Expenditures

12102000

Quarters > 1 > cash Flow > cash From Investing

-12478000

Quarters > 1 > cash Flow > cash From Financing

20382000

Quarters > 1 > cash Flow > net Change In Cash

16808000

Quarters > 1 > cash Flow > currency_symbol

EUR

Quarters > 1 > ratios > PE

0.4229758032033863

Quarters > 1 > ratios > PB

6.163287907523677

Quarters > 1 > ratios > ROE

3.838483838803195

Quarters > 1 > ratios > ROA

2.487911178063604

Quarters > 1 > ratios > FCF

-3398000

Quarters > 1 > ratios > Piotroski FScore

3

Quarters > 1 > ratios > fcf Percent

-0.021277661586244036

Quarters > 1 > health Score

44

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

154892000

Quarters > 2 > income Statement > cost Of Revenue

64494000

Quarters > 2 > income Statement > gross Profit

90398000

Quarters > 2 > income Statement > operating Expenses

67379000

Quarters > 2 > income Statement > operating Income

23019000

Quarters > 2 > income Statement > interest Expense

629000

Quarters > 2 > income Statement > pretax Income

22849000

Quarters > 2 > income Statement > net Income

18101000

Quarters > 2 > income Statement > eps

0.35388421602886505

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

51149498

Quarters > 2 > income Statement > income Tax Expense

4773000

Quarters > 2 > income Statement > EBITDA

30145000

Quarters > 2 > income Statement > operating Margin

14.861322728094414

Quarters > 2 > income Statement > total Other Income Expense Net

-170000

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

29306000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

116244000

Quarters > 2 > balance Sheet > inventories

319412000

Quarters > 2 > balance Sheet > total Current Assets

467855000

Quarters > 2 > balance Sheet > property Plant Equipment

288189000

Quarters > 2 > balance Sheet > total Assets

813963000

Quarters > 2 > balance Sheet > payables

90839000

Quarters > 2 > balance Sheet > short Term Debt

23116000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

214495000

Quarters > 2 > balance Sheet > equity

589872999

Quarters > 2 > balance Sheet > currency_symbol

-

Quarters > 2 > cash Flow > net Income

18101000

Quarters > 2 > cash Flow > depreciation

7281000

Quarters > 2 > cash Flow > change In Working Capital

32136000

Quarters > 2 > cash Flow > cash From Operations

18445000

Quarters > 2 > cash Flow > capital Expenditures

8057000

Quarters > 2 > cash Flow > cash From Investing

-11738000

Quarters > 2 > cash Flow > cash From Financing

-6451000

Quarters > 2 > cash Flow > net Change In Cash

2120000

Quarters > 2 > cash Flow > currency_symbol

EUR

Quarters > 2 > ratios > PE

0.35388421602886505

Quarters > 2 > ratios > PB

5.889129731922516

Quarters > 2 > ratios > ROE

3.0686266417832764

Quarters > 2 > ratios > ROA

2.223811156035348

Quarters > 2 > ratios > FCF

10388000

Quarters > 2 > ratios > Piotroski FScore

4

Quarters > 2 > ratios > fcf Percent

0.06706608475582987

Quarters > 2 > health Score

56

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

199137000

Quarters > 3 > income Statement > cost Of Revenue

87567000

Quarters > 3 > income Statement > gross Profit

111570000

Quarters > 3 > income Statement > operating Expenses

79201000

Quarters > 3 > income Statement > operating Income

32369000

Quarters > 3 > income Statement > interest Expense

730000

Quarters > 3 > income Statement > pretax Income

32255000

Quarters > 3 > income Statement > net Income

23389000

Quarters > 3 > income Statement > eps

0.45726743984857876

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

51149498

Quarters > 3 > income Statement > income Tax Expense

8800000

Quarters > 3 > income Statement > EBITDA

40412000

Quarters > 3 > income Statement > operating Margin

16.254638766276482

Quarters > 3 > income Statement > total Other Income Expense Net

-114000

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

27186000

Quarters > 3 > balance Sheet > short Term Investments

227000

Quarters > 3 > balance Sheet > receivables

129502000

Quarters > 3 > balance Sheet > inventories

329954000

Quarters > 3 > balance Sheet > total Current Assets

491575000

Quarters > 3 > balance Sheet > property Plant Equipment

286622000

Quarters > 3 > balance Sheet > total Assets

832022000

Quarters > 3 > balance Sheet > payables

125328000

Quarters > 3 > balance Sheet > short Term Debt

23691000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

249555000

Quarters > 3 > balance Sheet > equity

572028000

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

23389000

Quarters > 3 > cash Flow > depreciation

7427000

Quarters > 3 > cash Flow > change In Working Capital

63642000

Quarters > 3 > cash Flow > cash From Operations

72515000

Quarters > 3 > cash Flow > capital Expenditures

26342000

Quarters > 3 > cash Flow > cash From Investing

-41796000

Quarters > 3 > cash Flow > cash From Financing

-21087000

Quarters > 3 > cash Flow > net Change In Cash

9632000

Quarters > 3 > cash Flow > currency_symbol

EUR

Quarters > 3 > ratios > PE

0.45726743984857876

Quarters > 3 > ratios > PB

6.072847162148007

Quarters > 3 > ratios > ROE

4.088785863629053

Quarters > 3 > ratios > ROA

2.811103552550293

Quarters > 3 > ratios > FCF

46173000

Quarters > 3 > ratios > Piotroski FScore

4

Quarters > 3 > ratios > fcf Percent

0.23186549963090736

Quarters > 3 > health Score

67

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

763749000

Annuals > 0 > income Statement > cost Of Revenue

314066000

Annuals > 0 > income Statement > gross Profit

449683000

Annuals > 0 > income Statement > operating Expenses

270978000

Annuals > 0 > income Statement > operating Income

178705000

Annuals > 0 > income Statement > interest Expense

2350000

Annuals > 0 > income Statement > pretax Income

177831000

Annuals > 0 > income Statement > net Income

136881000

Annuals > 0 > income Statement > eps

2.6760966451713757

Annuals > 0 > income Statement > dividends Per Share

56451000

Annuals > 0 > income Statement > shares Outstanding

51149498

Annuals > 0 > income Statement > income Tax Expense

40814000

Annuals > 0 > income Statement > EBITDA

208196000

Annuals > 0 > income Statement > operating Margin

23.39839397498393

Annuals > 0 > income Statement > total Other Income Expense Net

-874000

Annuals > 0 > income Statement > currency_symbol

-

Annuals > 0 > balance Sheet > cash

27186000

Annuals > 0 > balance Sheet > short Term Investments

227000

Annuals > 0 > balance Sheet > receivables

129502000

Annuals > 0 > balance Sheet > inventories

329954000

Annuals > 0 > balance Sheet > total Current Assets

491575000

Annuals > 0 > balance Sheet > property Plant Equipment

286622000

Annuals > 0 > balance Sheet > total Assets

832022000

Annuals > 0 > balance Sheet > payables

75719000

Annuals > 0 > balance Sheet > short Term Debt

41330000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

249555000

Annuals > 0 > balance Sheet > equity

572028000

Annuals > 0 > balance Sheet > currency_symbol

-

Annuals > 0 > cash Flow > net Income

136881000

Annuals > 0 > cash Flow > depreciation

28015000

Annuals > 0 > cash Flow > change In Working Capital

-24123000

Annuals > 0 > cash Flow > cash From Operations

136643000

Annuals > 0 > cash Flow > capital Expenditures

59119000

Annuals > 0 > cash Flow > cash From Investing

-75782000

Annuals > 0 > cash Flow > cash From Financing

-58997000

Annuals > 0 > cash Flow > net Change In Cash

1864000

Annuals > 0 > cash Flow > currency_symbol

-

Annuals > 0 > ratios > PE

2.6760966451713757

Annuals > 0 > ratios > PB

6.072847162148007

Annuals > 0 > ratios > ROE

23.9290734020013

Annuals > 0 > ratios > ROA

16.45160825074337

Annuals > 0 > ratios > FCF

77524000

Annuals > 0 > ratios > Piotroski FScore

3

Annuals > 0 > ratios > fcf Percent

0.10150455188812031

Annuals > 0 > health Score

75

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

829509000

Annuals > 1 > income Statement > cost Of Revenue

346165000

Annuals > 1 > income Statement > gross Profit

483344000

Annuals > 1 > income Statement > operating Expenses

263090000

Annuals > 1 > income Statement > operating Income

219473000

Annuals > 1 > income Statement > interest Expense

948000

Annuals > 1 > income Statement > pretax Income

220408000

Annuals > 1 > income Statement > net Income

170335000

Annuals > 1 > income Statement > eps

3.202267258234321

Annuals > 1 > income Statement > dividends Per Share

69049000

Annuals > 1 > income Statement > shares Outstanding

53192000

Annuals > 1 > income Statement > income Tax Expense

50109000

Annuals > 1 > income Statement > EBITDA

238017000

Annuals > 1 > income Statement > operating Margin

26.458181888321885

Annuals > 1 > income Statement > total Other Income Expense Net

154000

Annuals > 1 > income Statement > currency_symbol

-

Annuals > 1 > balance Sheet > cash

25322000

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

143314000

Annuals > 1 > balance Sheet > inventories

337968000

Annuals > 1 > balance Sheet > total Current Assets

511124000

Annuals > 1 > balance Sheet > property Plant Equipment

253652000

Annuals > 1 > balance Sheet > total Assets

799884000

Annuals > 1 > balance Sheet > payables

109121000

Annuals > 1 > balance Sheet > short Term Debt

13185000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

256390000

Annuals > 1 > balance Sheet > equity

539387000

Annuals > 1 > balance Sheet > currency_symbol

-

Annuals > 1 > cash Flow > net Income

170335000

Annuals > 1 > cash Flow > depreciation

24331000

Annuals > 1 > cash Flow > change In Working Capital

-10525000

Annuals > 1 > cash Flow > cash From Operations

113247000

Annuals > 1 > cash Flow > capital Expenditures

53794000

Annuals > 1 > cash Flow > cash From Investing

-52028000

Annuals > 1 > cash Flow > cash From Financing

-160842000

Annuals > 1 > cash Flow > net Change In Cash

-99623000

Annuals > 1 > cash Flow > currency_symbol

EUR

Annuals > 1 > ratios > PE

3.202267258234321

Annuals > 1 > ratios > PB

6.697521365550153

Annuals > 1 > ratios > ROE

31.579366948035453

Annuals > 1 > ratios > ROA

21.294962769601593

Annuals > 1 > ratios > FCF

59453000

Annuals > 1 > ratios > Piotroski FScore

3

Annuals > 1 > ratios > fcf Percent

0.07167251952661152

Annuals > 1 > health Score

73

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

817698000

Annuals > 2 > income Statement > cost Of Revenue

320956000

Annuals > 2 > income Statement > gross Profit

496742000

Annuals > 2 > income Statement > operating Expenses

243004000

Annuals > 2 > income Statement > operating Income

255848000

Annuals > 2 > income Statement > interest Expense

849000

Annuals > 2 > income Statement > pretax Income

257768000

Annuals > 2 > income Statement > net Income

199669000

Annuals > 2 > income Statement > eps

3.7345041708749487

Annuals > 2 > income Statement > dividends Per Share

51007000

Annuals > 2 > income Statement > shares Outstanding

53466000

Annuals > 2 > income Statement > income Tax Expense

58302000

Annuals > 2 > income Statement > EBITDA

276609000

Annuals > 2 > income Statement > operating Margin

31.288813229334057

Annuals > 2 > income Statement > total Other Income Expense Net

1920000

Annuals > 2 > income Statement > currency_symbol

-

Annuals > 2 > balance Sheet > cash

124945000

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

184159000

Annuals > 2 > balance Sheet > inventories

311944000

Annuals > 2 > balance Sheet > total Current Assets

624949000

Annuals > 2 > balance Sheet > property Plant Equipment

215541000

Annuals > 2 > balance Sheet > total Assets

878703000

Annuals > 2 > balance Sheet > payables

128484000

Annuals > 2 > balance Sheet > short Term Debt

12725000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

355550000

Annuals > 2 > balance Sheet > equity

520012000

Annuals > 2 > balance Sheet > currency_symbol

-

Annuals > 2 > cash Flow > net Income

199669000

Annuals > 2 > cash Flow > depreciation

22871000

Annuals > 2 > cash Flow > change In Working Capital

516000

Annuals > 2 > cash Flow > cash From Operations

237317000

Annuals > 2 > cash Flow > capital Expenditures

51388000

Annuals > 2 > cash Flow > cash From Investing

-57160000

Annuals > 2 > cash Flow > cash From Financing

-154247000

Annuals > 2 > cash Flow > net Change In Cash

25910000

Annuals > 2 > cash Flow > currency_symbol

EUR

Annuals > 2 > ratios > PE

3.7345041708749487

Annuals > 2 > ratios > PB

6.9828480427374755

Annuals > 2 > ratios > ROE

38.39699853080313

Annuals > 2 > ratios > ROA

22.72314991527285

Annuals > 2 > ratios > FCF

185929000

Annuals > 2 > ratios > Piotroski FScore

4

Annuals > 2 > ratios > fcf Percent

0.2273810135282219

Annuals > 2 > health Score

82

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

648677000

Annuals > 3 > income Statement > cost Of Revenue

285219000

Annuals > 3 > income Statement > gross Profit

363458000

Annuals > 3 > income Statement > operating Expenses

181724000

Annuals > 3 > income Statement > operating Income

181734000

Annuals > 3 > income Statement > interest Expense

905000

Annuals > 3 > income Statement > pretax Income

182446000

Annuals > 3 > income Statement > net Income

153077000

Annuals > 3 > income Statement > eps

2.7629232546386544

Annuals > 3 > income Statement > dividends Per Share

21132000

Annuals > 3 > income Statement > shares Outstanding

55404000

Annuals > 3 > income Statement > income Tax Expense

29551000

Annuals > 3 > income Statement > EBITDA

204715000

Annuals > 3 > income Statement > operating Margin

28.016100462942266

Annuals > 3 > income Statement > total Other Income Expense Net

894000

Annuals > 3 > income Statement > currency_symbol

-

Annuals > 3 > balance Sheet > cash

99035000

Annuals > 3 > balance Sheet > short Term Investments

-

Annuals > 3 > balance Sheet > receivables

160063000

Annuals > 3 > balance Sheet > inventories

245473000

Annuals > 3 > balance Sheet > total Current Assets

510108000

Annuals > 3 > balance Sheet > property Plant Equipment

181775000

Annuals > 3 > balance Sheet > total Assets

732676000

Annuals > 3 > balance Sheet > payables

97407000

Annuals > 3 > balance Sheet > short Term Debt

6417000

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

259369000

Annuals > 3 > balance Sheet > equity

470976000

Annuals > 3 > balance Sheet > currency_symbol

-

Annuals > 3 > cash Flow > net Income

153077000

Annuals > 3 > cash Flow > depreciation

21364000

Annuals > 3 > cash Flow > change In Working Capital

-29087000

Annuals > 3 > cash Flow > cash From Operations

149221000

Annuals > 3 > cash Flow > capital Expenditures

40940000

Annuals > 3 > cash Flow > cash From Investing

-40907000

Annuals > 3 > cash Flow > cash From Financing

-62441000

Annuals > 3 > cash Flow > net Change In Cash

45873000

Annuals > 3 > cash Flow > currency_symbol

EUR

Annuals > 3 > ratios > PE

2.7629232546386544

Annuals > 3 > ratios > PB

7.989334534243784

Annuals > 3 > ratios > ROE

32.5020807854328

Annuals > 3 > ratios > ROA

20.892863967156014

Annuals > 3 > ratios > FCF

108281000

Annuals > 3 > ratios > Piotroski FScore

3

Annuals > 3 > ratios > fcf Percent

0.16692591227991743

Annuals > 3 > health Score

78

Valuation > metrics > PE

0.2014

Valuation > metrics > PB

5.587312024970688

Valuation > final Score

44.12687975029313

Valuation > verdict

5.9% Undervalued

Profitability > metrics > ROE

9.33336764580522

Profitability > metrics > ROA

10.377387171017924

Profitability > metrics > Net Margin

0.27570757294284776

Profitability > final Score

79

Profitability > verdict

Adequate

Risk > metrics > Debt Equity

0.4652578180162995

Risk > metrics > Interest Coverage

89.80449141347424

Risk > final Score

100

Risk > verdict

Low

Liquidity > metrics > Current Ratio

4.350634093207812

Liquidity > metrics > Quick Ratio

1.9015171555278922

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

40

Prev Valuations > 1

41.10870268077484

Prev Valuations > 2

40

Prev Profitabilities > 0

41

Prev Profitabilities > 1

35

Prev Profitabilities > 2

40

Prev Risks > 0

88

Prev Risks > 1

100

Prev Risks > 2

100

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T23:13:36.003Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-02-25

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

AfterMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-